ADLINACOGENE CIVAPARVOVEC
UNII J177M7U2XK

Substance Identification & Data

This profile provides standardized clinical and technical data for Adlinacogene Civaparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J177M7U2XK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2143579-02-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
J177M7U2XK
CAS Registry Number
2143579-02-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ADLINACOGENE CIVAPARVOVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10978
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Adlinacogene Civaparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ADLINACOGENE CIVAPARVOVEC

Common Names & Synonyms

ADLINACOGENE CIVAPARVOVEC [INN]
SB-FIX

Systematic Nomenclature

A RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS TYPE 2/6 (RAAV REP2-CAP6) VECTOR, WHICH CONTAINS A PROMOTERLESS HUMAN COAGULATION FACTOR IX (HF9, FACTOR IX OR FIX) TRANSGENE CASSETTE, ENCODING EXONS 2-8 AND SPLICE ACCEPTOR SITE SEQUENCE (SA) FROM HF9 EXON 2, FLANKED BY A SEQUENCE HOMOLOGOUS TO THE ZINC-FINGER NUCLEASE (ZFN) CLEAVAGE SITE OF THE HUMAN ALBUMIN (HALB) INTRON 1